V TheIndian pharmaceuticals industry has grown

from a US$ 0.32 billion turnover in 1980 to

approximately US$ 21.26 billion in 2009-
10.The country now ranks 3rd in terms of
volume of production (10% of global share).
 r

 
` `
` 
` 
` 
` 
` 
` 

      

 
 2 2
 2 2 2 2
  


Ô

 
2  
 2 
222


 
 
22  

2 


 2
22  



 
 22

V India currently exports drug intermediates, Active Pharmaceutical
Ingredients (APIs), Finished Dosage Formulations (FDFs), Bio-
Pharmaceuticals, Clinical Services to various parts of the world.
G
  

  2 

 2  2 


    
2
 




 
 


   2 

2
   222 

    2 2 

    

 
 0ARKET DEVELOP0ENT 0ARKET ACCESS
ASSISTANCE (0DA) INITIATIVE (0AI)

V Under 0DA Scheme, V It is intended to provide

exporters with annual export financial assistance for
turnover upto Rs. 5 crores medium term export
are eligible for financial promotion efforts with a
assistance for a range of sharp focus on a country &
export promotion activities product. EPCs, Agencies of
such as participation in trade
fairs, buyer-seller meets State Govt., etc. are eligible
abroad or in India, export for the assistance under the
promotion seminars etc. scheme.
Additional resources have been made available under the 0DA and 0AI
Scheme. PHAR0EXCIL, the Export Promotion Council has been
provided funds for Brand Promotion of Indian pharmaceutical industry in
Africa under 0AI Scheme.
FOCUS 0ARKET
SCHE0E
Objective is to offset high
freight cost and other
externalities to select
international markets with a
view to enhance our export
competitiveness in these
countries.
[ Incentive available under Focus
0arket Scheme has been raised
from 2.5% to 3%. Pharma
sector will also benefit with
this.
FOCUS PRODUCT SCHE0E
Objective is to incentivise
export of such products,
which have high employment
intensity in rural and semi
urban areas, so as to offset
infrastructure inefficiencies
and other associated costs
involved in marketing of
these products
V Incentive under Focus
Product Scheme has been
raised from 1.25% to 2%.
[ 0arket Linked Focus Product Scheme (0LFPS) has been greatly expanded
by inclusion of products classified under as many as 153 ITC(HS) Codes at 4
digit level.
[ Some major products include; Pharmaceuticals, textile madeups,, glass
products, certain iron and steel products and certain articles of aluminium etc.
[ Pharmaceutical has been included in 0arket linked Focus Product Scheme.
Thus exports made to 13 identified markets (Algeria, Egypt, Kenya, Nigeria,
South Africa and Tanzania, Brazil, 0exico, Ukraine, Vietnam, Cambodia,
Australia, New Zealand) will be eligible for benefit under this Scheme.
 TOWN OF EPCG SCHEME
EXPORT RELAXATION
EXCELLENCE
[ Zero duty has been introduced
[ Re-import of exported under EPCG Scheme for aiding
pharmaceutical samples by technological up gradation for
EOUs without payment of duty pharmaceutical sector .
for statutory requirement of
Stability or Retention has been
allowed and notified by DOR.
 Pharma Export Promotion Council (Pharmexcil)

i. Organization of 40th Annual conference of Indian Pharmacological Society at NIPER,

0ohali .
ii. Organizing International Conference on Pharmaceutical 0arket Prognosis-2012 in
collaboration with FICCI .
iii. Organization of International Seminar on Pharmaceutical Pricing & Regulatory
Framework for Affordable 0edicines by NPPA
iv. Study on ³Assessment of number of Pharma SSI units requiring technological
upgradation´
v. Preparation of corporate film of Pharma Industry in India .
vi. Procurement of International market Reports from reputed publishers and all
Pharmacopoeias .
vii. Organizing of International conference on Biotechnological approaches to Neuro
immunomodulation & Infectious Diseases.
viii. Organization of ³International conference on new developments in drug discovery
from natural products and traditional medicines´ by NIPER .
ix. Participation in ³Pride of India ISC Expo 2009 ± 96th Indian ScienceCongress´.
x. Organization of conference on Pharmaceuticals-³Pharmaceuticals 2014; will India
leap forward´ in collaboration with FICCI .
xi. Conducting of Pre-feasibility study for development of a Green Field Project for
0edical Devices cluster in Gujarat and a Brown Field Project for Bulk Drugs cluster
in Andhra Pradesh .
xii. Conducting of a study on 0edical Devices± sub sector of Pharma by NIPER,
Ahemdabad .
ü Emergence of India as leading country in Global Pharmaceutical 0arket
ü Export to be the major thrust of the Industry
ü Indian companies can still continue to market and export generic drugs that
are off patent
ü 0ore Investment required in R&D
ü Fiscal Incentives for R&D should be provided on a long term basis of
around 10 years
ü Clear Guidelines required on OTC Drugs
ü Higher Budget Outlay for Healthcare Services required
 6
 

 
 
 6
  
   




 ` `

















! 6
 6
 6
 
   

    
6

 6